ETF Holdings Breakdown of GMAB

Stock NameGenmab AS
TickerGMAB(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS3723032062
LEI529900MTJPDPE4MHJ122

News associated with GMAB

CANADA LIFE ASSURANCE Co Sells 1,143 Shares of Genmab A/S (NASDAQ:GMAB)
CANADA LIFE ASSURANCE Co lowered its stake in Genmab A/S (NASDAQ:GMAB – Free Report) by 42.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,567 shares of the company’s stock after selling 1,143 shares during the quarter. CANADA LIFE ASSURANCE […] - 2025-05-01 08:50:46
Bank of Montreal Can Has $670,000 Stock Holdings in Genmab A/S (NASDAQ:GMAB)
Bank of Montreal Can decreased its stake in Genmab A/S (NASDAQ:GMAB – Free Report) by 57.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 32,109 shares of the company’s stock after selling 43,710 shares during the quarter. Bank of Montreal Can’s holdings in Genmab […] - 2025-04-21 07:38:47
Envestnet Asset Management Inc. Has $15.11 Million Holdings in Genmab A/S (NASDAQ:GMAB)
Envestnet Asset Management Inc. decreased its position in Genmab A/S (NASDAQ:GMAB – Free Report) by 30.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 723,781 shares of the company’s stock after selling 319,779 shares during the quarter. Envestnet Asset Management Inc. owned […] - 2025-04-16 08:05:01
Genmab A/S (NASDAQ:GMAB) Shares Sold by Orion Portfolio Solutions LLC
Orion Portfolio Solutions LLC lessened its stake in shares of Genmab A/S (NASDAQ:GMAB – Free Report) by 18.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 17,376 shares of the company’s stock after selling 3,919 shares during the quarter. Orion Portfolio Solutions LLC’s […] - 2025-04-09 08:02:51
Genmab A/S (NASDAQ:GMAB) Stock Rating Lowered by Sanford C. Bernstein
Genmab A/S (NASDAQ:GMAB – Get Free Report) was downgraded by analysts at Sanford C. Bernstein from a “market perform” rating to an “underperform” rating in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. GMAB has been the subject of several other reports. Truist Financial reduced their price objective on Genmab A/S […] - 2025-04-03 07:41:01
Genmab A/S (NASDAQ:GMAB) Receives $41.33 Consensus PT from Brokerages
Shares of Genmab A/S (NASDAQ:GMAB – Get Free Report) have been given an average rating of “Moderate Buy” by the thirteen analysts that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, eight have assigned a buy recommendation and […] - 2025-04-02 05:51:03
Genmab A/S (NASDAQ:GMAB) Holdings Decreased by Envestnet Portfolio Solutions Inc.
Envestnet Portfolio Solutions Inc. reduced its holdings in Genmab A/S (NASDAQ:GMAB – Free Report) by 29.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,077 shares of the company’s stock after selling 8,330 shares during the period. Envestnet Portfolio […] - 2025-03-27 08:43:00
Genmab A/S (NASDAQ:GMAB) Shares Sold by Assetmark Inc.
Assetmark Inc. lowered its position in Genmab A/S (NASDAQ:GMAB – Free Report) by 78.1% during the fourth quarter, Holdings Channel.com reports. The fund owned 18,109 shares of the company’s stock after selling 64,520 shares during the quarter. Assetmark Inc.’s holdings in Genmab A/S were worth $378,000 at the end of the most recent quarter. Other […] - 2025-03-13 08:37:04
Genmab A/S (NASDAQ:GMAB) Raised to Outperform at William Blair
Genmab A/S (NASDAQ:GMAB – Get Free Report) was upgraded by William Blair from a “market perform” rating to an “outperform” rating in a note issued to investors on Tuesday, Marketbeat reports. William Blair also issued estimates for Genmab A/S’s FY2028 earnings at $4.06 EPS. A number of other brokerages have also weighed in on GMAB. […] - 2025-03-13 06:18:47
Genmab A/S (NASDAQ:GMAB) Stock Holdings Trimmed by QRG Capital Management Inc.
QRG Capital Management Inc. lowered its holdings in shares of Genmab A/S (NASDAQ:GMAB – Free Report) by 19.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,857 shares of the company’s stock after selling 5,579 shares during the period. QRG Capital […] - 2025-03-06 11:19:40
Blue Trust Inc. Grows Stock Position in Genmab A/S (NASDAQ:GMAB)
Blue Trust Inc. grew its holdings in Genmab A/S (NASDAQ:GMAB – Free Report) by 33.4% during the fourth quarter, HoldingsChannel reports. The fund owned 5,757 shares of the company’s stock after purchasing an additional 1,442 shares during the period. Blue Trust Inc.’s holdings in Genmab A/S were worth $120,000 as of its most recent SEC […] - 2025-02-07 09:38:11
Blue Trust Inc. Grows Stock Position in Genmab A/S (NASDAQ:GMAB)
Blue Trust Inc. grew its holdings in Genmab A/S (NASDAQ:GMAB – Free Report) by 33.4% during the fourth quarter, HoldingsChannel reports. The fund owned 5,757 shares of the company’s stock after purchasing an additional 1,442 shares during the period. Blue Trust Inc.’s holdings in Genmab A/S were worth $120,000 as of its most recent SEC […] - 2025-02-07 08:32:57

GMAB institutional holdings

The following institutional investment holdings of GMAB have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 19,900USD 386,458
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 19,900USD 386,458 -6.1%
2024-12-10 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 89,899 0.3%DKK 19,710,500 -0.8%
2024-12-10 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 89,899 0.3%DKK 19,710,500 -0.8%
2024-12-10 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 89,899 0.3%DKK 19,710,500 -0.8%
2024-12-10 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 14,633 0.2%DKK 3,208,309 -1.0%
2024-12-10 IE00B1YZSC51 (iShares Core MSCI Europe UCITS ETF EUR (Dist)) 51,983DKK 10,849,975 -0.3%
2024-12-10 IE00BL4KKW48 (iShares Core MSCI Europe UCITS ETF MXN Hedged (Acc)) 51,983DKK 10,849,975 -0.3%
2024-12-10 IE00B4K48X80 (iShares Core MSCI Europe UCITS ETF EUR (Acc)) 49,688DKK 10,370,959 -0.3%
2024-12-10 IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc)) 23,246 198.0%DKK 5,096,723 199.2%
2024-12-10 IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist)) 23,246 198.0%DKK 5,096,723 199.2%
2024-12-10 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 7,044DKK 1,544,408 -1.2%
2024-12-10 IE00BHZPJ676 (iShares MSCI Europe ESG Enhanced UCITS ETF EUR Inc GBP) 11,640DKK 2,429,519 -0.3%
2024-12-10 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 1,081DKK 237,011 -1.2%
2024-12-10 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 1,081DKK 237,011 -1.2%
2024-12-10 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 4,726 0.7%DKK 1,036,183 -0.4%
2024-12-10 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 4,726 0.7%DKK 1,036,183 -0.4%
2024-12-10 IE00BFNM3D14 (iShares MSCI Europe ESG Screened UCITS ETF EUR (Acc) GBP) 22,838 0.1%DKK 4,766,784 -0.2%
2024-12-10 IE00BFNM3F38 (iShares MSCI Europe ESG Screened UCITS ETF) 22,838 0.1%DKK 4,766,784 -0.2%
2024-12-10 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 57,867DKK 12,687,432 -1.2%
2024-12-10 IE00B14X4N27 (iShares Developed World ex-UK UCITS ETF EUR (Dist)) 8,427DKK 1,758,897 -0.3%
2024-12-10 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 28,703 -1.1%DKK 6,293,179 -2.2%
2024-12-10 IE00B86MWN23 (iShares Edge MSCI Europe Minimum Volatility UCITS ETF EUR (Acc) USD) 11,494DKK 2,399,046 -0.3%
2024-12-10 IE00BG13YK79 (iShares Edge MSCI Europe Minimum Volatility UCITS ETF EUR (Dist)) 11,494DKK 2,399,046 -0.3%
2024-12-10 DE000A0Q4R36 (iShares STOXX Europe 600 Health Care UCITS ETF DE) 26,343DKK 5,498,353 -0.3%
2024-12-10 IE00BMW42181 (iShares MSCI Europe Health Care Sector UCITS ETF) 22,206DKK 4,634,872 -0.3%
2024-12-10 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 416DKK 71,595 -0.7%
2024-12-10 IE00BVDPJP67 (iShares MSCI Europe ex-UK GBP Hedged UCITS ETF (Dist)) 1,303DKK 224,251 -0.7%
2024-12-10 IE00BKVL7D31 (iShares Edge MSCI Europe Minimum Volatility ESG UCITS ETF EUR (Acc)) 1,203DKK 251,092 -0.3%
2024-12-10 IE00BMDBM966 (iShares Edge MSCI Europe Minimum Volatility ESG UCITS ETF) 1,203DKK 251,092 -0.3%
2024-12-10 IE000KJPDY61 (iShares World Equity High Income UCITS ETF USD Inc) 891DKK 195,353 -1.2%
2024-12-10 IE000D8XC064 (iShares World Equity Enhanced Active UCITS ETF USD (Acc)) 53DKK 11,620 -1.2%
2024-12-10 IE00000EF730 (iShares Europe Equity Enhanced Active UCITS ETF EUR (Acc)) 256DKK 53,433 -0.3%
2024-12-10 IE000YNE6S57 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Dist)) 6DKK 1,316 -1.1%
2024-12-10 IE0001YGXFO5 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Acc)) 6DKK 1,316 -1.1%
Total =772,121 DKK 158,162,856
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.